Cargando…
Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
Naltrexone and naloxone are classical opioid antagonists. In substantially lower than standard doses, they exert different pharmacodynamics. Low-dose naltrexone (LDN), considered in a daily dose of 1 to 5 mg, has been shown to reduce glial inflammatory response by modulating Toll-like receptor 4 sig...
Autores principales: | Toljan, Karlo, Vrooman, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313374/ https://www.ncbi.nlm.nih.gov/pubmed/30248938 http://dx.doi.org/10.3390/medsci6040082 |
Ejemplares similares
-
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
por: Younger, Jarred, et al.
Publicado: (2014) -
Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN)
por: Chopra, Pradeep, et al.
Publicado: (2013) -
Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series
por: McKenzie-Brown, Anne Marie, et al.
Publicado: (2023) -
No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study
por: Raknes, Guttorm, et al.
Publicado: (2020) -
A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study
por: Raknes, Guttorm, et al.
Publicado: (2016)